Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25547
Title: Systematic Quantification of Histological Ventricular Fibrosis in Isolated Mitral Valve Prolapse and Sudden Cardiac Death.
Austin Authors: Han, Hui-Chen ;Parsons, Sarah A;Curl, Claire L;Teh, Andrew W ;Raaijmakers, Antonia J A;Koshy, Anoop N ;Leong, Trishe;Burrell, Louise M ;O'Donnell, David ;Vohra, Jitendra K;Kalman, Jonathan M;Sanders, Prashanthan;Hare, David L ;Farouque, Omar ;Delbridge, Lea M D;Lim, Han S 
Affiliation: Department of Cardiology, Eastern Health and Monash University, Victoria, Australia
Department of Cardiology, Northern Health and University of Melbourne, Victoria, Australia
Victorian Institute of Forensic Medicine and Monash University Department of Forensic Medicine, Victoria, Australia
Department of Cardiology, Royal Melbourne Hospital and University of Melbourne, Victoria, Australia
Cardiology
Department of Physiology, University of Melbourne, Victoria, Australia
Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, South Australia, Australia
Medicine (University of Melbourne)
Anatomical Pathology
University of Melbourne, Victoria, Australia
Issue Date: 24-Dec-2020
Date: 2020-12-24
Publication information: Heart Rhythm 2020; online first: 24 December
Abstract: Cardiac fibrosis in mitral valve prolapse (MVP) is implicated in the development of sudden cardiac death (SCD), however, the pattern remains poorly characterized. This study aimed to systematically quantify left and right ventricular fibrosis in individuals with isolated MVP and SCD (iMVP-SCD), whereby other potential causes of death are excluded, compared to a control cohort. Individuals with iMVP-SCD were identified from the Victorian Institute of Forensic Medicine, Australia and matched for age, sex and body-mass index to control cases with non-cardiac death. Cardiac tissue sections were analyzed to determine collagen deposition in the left ventricular free wall (anterior, lateral and posterior portions), interventricular septum and right ventricle. Within the iMVP-SCD cases, the endocardial-epicardial distribution of fibrosis within the LV was specifically characterized. There were 17 cases with iMVP-SCD matched 1:1 with 17 controls yielding 149 samples and 1,788 histological regions. The iMVP-SCD group had increased left ventricular (anterior, lateral and posterior; all p<0.001) and interventricular septum fibrosis (p<0.001), but similar amounts of right ventricular fibrosis (p=0.62) compared to controls. In iMVP-SCD, left ventricular fibrosis was significantly higher in the lateral and posterior wall compared to the anterior wall and interventricular septum (all p<0.001). Within the lateral and posterior wall, iMVP-SCD cases had a significant endocardial-to-epicardial gradient of cardiac fibrosis (p<0.01) similar to other known conditions which cause cardiac remodeling. Our study indicates that non-uniform left ventricular remodeling with both localized and generalized left ventricular fibrosis is important in the pathogenesis of SCD in individuals with MVP.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25547
DOI: 10.1016/j.hrthm.2020.12.021
Journal: Heart Rhythm
PubMed URL: 33359875
Type: Journal Article
Subjects: cardiac fibrosis
mitral valve disease
mitral valve prolapse
sudden death
valvular heart disease
Appears in Collections:Journal articles

Show full item record

Page view(s)

74
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.